Merger Arbitrage Mondays – February 25, 2019
Merger activity increased last week with four new deals announced and four pending deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool (MAT) that automatically updates itself during market hours.
There were three new deals announced in the Deals in the Works section.
Deal Statistics:
New Deals:
- The acquisition of Immune Design (IMDZ) by Merck (MRK) for $300 million or $5.85 per share in cash.
- The acquisition of Citizens First Corporation (CZFC) by German American Bancorp (GABC) for $69.51 million in a cash plus stock deal. Under terms of the definitive agreement, Citizens First common shareholders (excluding 401(k) shareholders) will receive a fixed exchange ratio of 0.6629 shares of German American common stock for each share of Citizens First in a tax free exchange, and a cash payment of $5.80 per Citizens First share.
- The acquisition of Attunity (ATTU) by Qlik for $560 million or $23.50 per share in cash.
Only plus or premium subscribers can access this post. Subscribe today.
